REGULATED PRESS RELEASE published on 07/23/2025 at 17:45, 10 months 19 days ago Outcome of the optional dividend for the FY 2024-25: 64.2% of the dividend rights are distributed in the form of new ordinary shares, resulting in a capital increase of EUR 41.8 million Gimv reports 64.2% dividend rights for FY 2024-25 paid in new ordinary shares, increasing equity by EUR 41.8 million. Shareholders opt for shares in lieu of full cash dividend Ordinary Shares Gimv Dividend Capital Increase Equity
BRIEF published on 07/23/2025 at 07:50, 10 months 20 days ago Gimv Reinvests in Bugaboo-Joolz Merger to Drive Global Growth Innovative Design International Expansion Gimv Investment Bugaboo-Joolz Merger Stroller Market Growth
REGULATED PRESS RELEASE published on 07/23/2025 at 07:45, 10 months 20 days ago Gimv reinvests in the Bugaboo-Joolz combination after companies joining forces to accelerate growth in the worldwide stroller market Gimv reinvests in Bugaboo-Joolz combo to accelerate growth in the stroller market with a focus on international expansion and innovation. Partnership with Mubadala Capital, Bain Capital, and management Innovation Gimv International Growth Stroller Market Bugaboo-Joolz
BRIEF published on 07/22/2025 at 19:00, 10 months 20 days ago Gimv Invests in Hemink for Sustainable Real Estate Growth Sustainable Investment Real Estate Renovation Gimv Partnership Hemink Expansion Circular Maintenance
REGULATED PRESS RELEASE published on 07/22/2025 at 18:55, 10 months 20 days ago Gimv invests in Hemink, a Dutch renovation and maintenance specialist with focus on sustainable real estate Gimv invests in Hemink, a Dutch specialist in sustainable real estate renovation and maintenance. Hemink aims to expand nationally in collaboration with Gimv, focusing on circular maintenance and renovation Gimv Sustainable Real Estate Hemink Property Maintenance Dutch Renovation
BRIEF published on 06/25/2025 at 17:50, 11 months 16 days ago Gimv's General Meeting Decisions and Updates Corporate Governance General Meeting Director Appointments Financial Year Change Gimv Dividend
REGULATED PRESS RELEASE published on 06/25/2025 at 17:45, 11 months 16 days ago Report (extra)ordinary general meeting of June 25, 2025 Gimv's GM approves gross dividend of EUR 2.60 per share and changes financial year end to Dec 31. Annual accounts for 2024-25 approved. Key appointments and new remuneration policy announced Appointments Gimv Financial Year Dividend GM
BRIEF published on 06/25/2025 at 07:35, 11 months 17 days ago Gimv Announces Optional Dividend Terms Shareholders Gimv Dividend Subscription Period Optional Dividend
REGULATED PRESS RELEASE published on 06/25/2025 at 07:30, 11 months 17 days ago Modalités du dividende optionnel Gimv offers optional dividend for shareholders to exchange for new shares at 40.04 euros or 22 dividend rights. Shareholders' choices accepted from July 2 to 22, 2025, 16:00 CET Shareholders Gimv Dividend New Shares Optional Dividend
BRIEF published on 06/24/2025 at 17:50, 11 months 17 days ago Gimv Acquires Majority Stake in Alpine for Growth and Market Expansion International Expansion Sustainability Focus Gimv Acquisition Alpine Growth Hearing Protection Market
Published on 06/12/2026 at 09:20, 1 hour 2 minutes ago CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights
Published on 06/12/2026 at 08:05, 2 hours 17 minutes ago Caledonia Mining Corporation Plc: Director/PDMR Shareholding Notification
Published on 06/12/2026 at 08:00, 2 hours 22 minutes ago Caledonia Mining Corporation Plc: Utilisation of the Block Admission in Respect of ATM Sales Agreement
Published on 06/12/2026 at 00:00, 10 hours 22 minutes ago Redwood AI Enters LOI to Explore Pathogen Tracking Through AI Genomics at the Border of Rwanda and the Democratic Republic of Congo with Aim of Potentially Tracing Ebola Virus Disease
Published on 06/12/2026 at 10:00, 22 minutes ago Kora Joins International Air Transport Association's (IATA) Payment Network to Power Airline Payments Across Africa
Published on 06/12/2026 at 09:35, 47 minutes ago Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis
Published on 06/12/2026 at 09:02, 1 hour 19 minutes ago CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights
Published on 06/12/2026 at 08:00, 2 hours 22 minutes ago EQS-Adhoc: Tirlán Co-operative Society Limited: RESULT OF SECONDARY SHARE SALE
Published on 06/12/2026 at 09:00, 1 hour 22 minutes ago Pricing of Green Senior Secured Notes due 2031 by Neoen FINCO PLC
Published on 06/11/2026 at 17:45, 16 hours 37 minutes ago BAIKOWSKI: Annual General Meeting of June 11, 2026 - Dividend of €0.30 per share, to be paid out on June 30, 2026
Published on 06/11/2026 at 08:45, 1 day 1 hour ago Air Liquide and ArianeGroup renew strategic industrial partnership with two major Ariane 6 contracts
Published on 06/11/2026 at 08:30, 1 day 1 hour ago Aéroports de Paris S.A - €600 million new bond issue